Prescribing for Diabetes, England - 2006/07 to 2016/17
Publication date: 09:30 August 01, 2017
Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2006 to March 2017.
Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.
- Drugs used in diabetes (British National Formulary (BNF) section 6.1) now make up 11.0 per cent of total primary care net ingredient costs (NIC) and 4.7 per cent of prescription items.
- In the financial year 2016/17 there were 52.0 million items prescribed for diabetes at a total net ingredient cost of £983.7 million. Up from 28.9 million prescription items and £572.4 million in 2006/07.
- Antidiabetic drugs (BNF section 6.1.2) make up 45.1 per cent of the total £983.7 million net ingredient cost of drugs used in diabetes and accounts for 72.0 per cent of prescription items for all diabetes prescribing.
|Date Range:||01 April 2006 to 31 March 2017|
|Geographical granularity:||Clinical Commissioning Groups|